Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-26 to 2025-03-19
Current total value of award: $105367.2
Description: 4567418335!XOLAIR 300 MG/2 ML SYRINGE 2ML